Envisioned Expansion: Respiratory Devices Market Poised to Hit US$ 55.9 Billion by 2033, Demonstrating a Substantial 8.7% CAGR
HomeHome > News > Envisioned Expansion: Respiratory Devices Market Poised to Hit US$ 55.9 Billion by 2033, Demonstrating a Substantial 8.7% CAGR

Envisioned Expansion: Respiratory Devices Market Poised to Hit US$ 55.9 Billion by 2033, Demonstrating a Substantial 8.7% CAGR

Nov 09, 2023

The Respiratory Devices Market size is projected to be valued at US$ 24.2 Billion in 2023 and is expected to rise to US$ 55.9 Billion by 2033. The sales of respiratory devices are expected to grow at a significant CAGR of 8.7% during the forecast period.

The prevalence of tobacco use and the rising incidence of respiratory disorders are some of the key factors propelling the growth of the worldwide respiratory devices market. Additionally, a preference for at-home oxygen therapy and technological advancements that lead to the development of novel oxygen therapy-delivery solutions are fueling the market’s expansion.

In addition to this, a sizable number of encouraging initiatives by public and private organizations are further supporting the market. For instance, in July 2022, OMRON Healthcare, the company’s healthcare branch, unveiled its most recent oxygen delivery system, the OMRON medical molecular sieve-based oxygen concentrator.

Click to Download Your Report with Stunning Visuals. @ https://www.futuremarketinsights.com/reports/sample/rep-gb-794

In recent years, home healthcare technologies have grown in acceptance and market share. An additional area of interest for both established international manufacturers and other emerging suppliers is the introduction of therapeutic respiratory equipment for home healthcare.

Key Takeaways from the Respiratory Devices Market

With over 30.0% of the market in 2022, North America held a dominant position thanks to favorable outpatient treatment reimbursement, economic expansion aided by expanding insurance coverage, U.S. healthcare center accounts, developing healthcare expertise, and improved healthcare systems.

According to University of Edinburgh research, in England COPD treatment costs is likely to exceed 2.5bn euro by 2030. This is indicative of increased health spending on the treatment of respiratory ailments, which represents the scope for the expansion in the U.K.

Knowledge at Your Fingertips: Unlock Insights from the Experts! @ https://www.futuremarketinsights.com/ask-question/rep-gb-794

It is anticipated that a significant portion of the population in developing countries like China and India will experience respiratory illnesses. Nearly 90% of COPD-related fatalities, according to data from the World Health Organization (WHO), take place in low- and middle-income countries.

The Positive Airway Pressure (PAP) devices category will continue to hold more than half of the global market share for devices. By the end of 2031, the segment is anticipated to control just slightly more than 35% of the market in terms of product type. According to FMI, hospitals as end users are likely to account for above 42% of the market by the end of 2031. Driven by higher footprint of patients, hospitals have continued accounting for leading share in the Respiratory Devices Market among end users.

Competitive Landscape:

Leading players are focusing on strategic acquisitions to strengthen their product portfolio. For instance, Masimo Corporation acquired TNI medical AG (“TNI”) for patients suffering from respiratory insufficiency to provide innovative pulmonary care therapy in 2020. Similarly, Resmed Inc. in 2019 completed the acquisition of HB Healthcare (HBH) and Propeller Health to provide connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and other respiratory conditions like asthma.

Drive Results with Your Customized Impactful Report! @ https://www.futuremarketinsights.com/customization-available/rep-gb-794

Companies operating in the respiratory devices market are focusing on strategic collaborations to address the requirements of an expanding patient pool. For instance, In June 2020, Medtronic plc entered into a partnership with Foxconn Industrial Internet to begin manufacturing Medtronic’s Puritan Bennett 560 (PB560) ventilators in the United States. Similarly, Smith’s Medical has signed a distribution partnership with Medline Industries for the distribution of the Portex acapella, a vibratory PEP therapy device to focus on the non-acute and home care channels in 2019.

There is ample focus on innovations and USFDA approval among players. Besides aiming at a competitive advantage, key players are focusing on the expansion of their global footprint as they expect approvals from regulatory authorities. For instance, In 2019, Masimo corporation got USFDA approval for Neonatal RD SET Pulse Oximetry Sensors with improved accuracy Specifications, O3 Regional Oximetry for use on neonatal and infant patients, Radius PPG, a first tetherless SET pulse oximetry sensor solution. Likewise, Masimo Corporation Rad-G Pulse Oximeter got USFDA approval in 2020 to treat respiratory disorders.

Most of the companies are focusing on new product launches with advanced technology coupled with new ventilation solution that provides respiratory support to neonates, infants, pediatrics, and adults. For instance, in 2019 ResMed Inc. launched an automated ResMed ReSupply solution to increase long-term therapy adherence and improve the satisfaction of patients suffering from sleep apnea disorders.

Respiratory Devices Market


End Users:

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.

Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.

Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033..

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.Christiana Corporate, 200 Continental Drive,Suite 401, Newark, Delaware – 19713, USAT: +1-845-579-5705For Sales Enquiries: [email protected]Website: https://www.futuremarketinsights.comLinkedIn| Twitter| Blogs | YouTube

Click to Download Your Report with Stunning Visuals. @ Key Takeaways from the Respiratory Devices Market Knowledge at Your Fingertips: Unlock Insights from the Experts! @Competitive Landscape:Drive Results with Your Customized Impactful Report! @Respiratory Devices MarketProduct:End Users:Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:: About Future Market Insights (FMI)Contact Us: For Sales Enquiries: Website: